Treatment with human mesenchymal stem cells (hMSCs), grown under hypoxic conditions, changes the immunological responses following acute myocardial infarction (AMI)

MedStar author(s):
Citation: Unpublished 2016/03/14Form of publication: Poster PresentationYear: 2016Conference information: MedStar Heart & Vascular Institute: MedStar Health Research Symposium, Columbia, MD, All authors: Luger D, Lipinski MJ, Westman P, Epstein SE Fiscal year: FY2016Local accession number: 2016_37Date added to catalog: 2017-05-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Poster Presentation MedStar Authors Catalog Poster Available

Powered by Koha